We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

0 hedge funds and large institutions have $0 invested in Imperva, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 161 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1620 (-162)

100% less funds holding in top 10

Funds holding in top 10: 110 (-11)

100% less capital invested

Capital invested by funds: $1.87B → $0 (-$1.87B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 161

Holders
Holders Change
-162
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
161
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

IMPV Hedge Fund Activity: Q1 2019 in Review

0 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q1 2019, worth a combined $0 — down 100% from $1.87B a quarter earlier.

Sellers outnumbered buyers: 161 funds closed out of IMPV and 0 opened new positions — a net loss of 161 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Eminence Capital, exiting entirely with an estimated $175M sold.

  • 0 institutional investors held Imperva, Inc. (IMPV) as of Q1 2019, down from 162 in Q4 2018.
  • Funds reported $0 of Imperva, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Imperva, Inc. positions in Q1 2019 and 161 closed out, a net change of -161 holders.
  • The largest Imperva, Inc. seller in Q1 2019 was Eminence Capital, an estimated $175M sold.

Based on aggregated 13F filings for Q1 2019.